C22.9
Malignant neoplasm of liver, not specified as primary or secondary
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code C22.9 refers to a malignant (cancerous) growth found in the liver that has not been specifically identified as either a primary or secondary tumor. The liver is a vital organ that performs numerous functions, including detoxification, protein synthesis, and production of biochemicals necessary for digestion. When a malignant neoplasm occurs in the liver, it can arise directly from liver cells or spread from other parts of the body. This condition requires careful diagnosis and management to determine the appropriate treatment approach.
Causes & Symptoms
Clinical Causes: Primary liver cancer (hepatocellular carcinoma) without specific classification Metastatic cancer that has spread to the liver from other organs Chronic liver diseases, such as hepatitis B or C infections, which can increase cancer risk Heavy alcohol consumption leading to liver cirrhosis Exposure to certain toxins or environmental carcinogens Certain inherited genetic conditions that predispose to liver cancer
Key Symptoms: Unexplained weight loss Persistent abdominal pain or discomfort A palpable mass or swelling in the upper right abdomen Jaundice, which causes yellowing of the skin and eyes Chronic fatigue and weakness Loss of appetite Nausea and vomiting Swelling due to fluid accumulation in the abdomen (ascites)
Diagnostic & Treatment
Diagnosis Path: Imaging tests such as ultrasound, CT scan, or MRI to visualize the liver and identify abnormalities Blood tests to evaluate liver function and detect tumor markers like alpha-fetoprotein (AFP) Biopsy procedures to obtain tissue samples for histopathological examination Additional assessments like PET scans or angiography to determine the extent of disease spread
Treatment Protocols: Surgical resection to remove the tumor if feasible Liver transplantation in eligible cases Locoregional therapies such as radiofrequency ablation, transarterial chemoembolization (TACE), or selective internal radiation therapy (SIRT) Systemic treatments which may include chemotherapy, targeted therapy, or immunotherapy Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C22.9 a billable ICD-10 code?
Yes, C22.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C22.9?
Clinical documentation must specify the nature of Malignant neoplasm of liver, not specified as primary or secondary and any associated comorbidities for accurate reporting.
Cite this Clinical Reference